Incidence and prevalence of autoimmune disease in the Swedish National Patient Register
European Journal of Epidemiology · 2026
DOI: 10.1007/s10654-026-01369-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Epidemiology, 2026. Verfasst von David Bergman und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177, Stockholm, Sweden. david.bergman.1@ki.se. Hauptthemen laut MEDLINE: Autoimmune Diseases, Registries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Standardized definitions of autoimmune disease (AD) are lacking. Therefore, we aim to propose a definition of AD for register-based research and estimate the burden of AD in Sweden as registered in the National Patient Register (NPR) from 1980 to 2023. METHODS: Leveraging the NPR, we defined AD as having at least two relevant International Classification of Diseases (ICD) codes representing AD. These codes could either represent the same disease or two different diseases. Age-standardized and age-specific incidence rates (IRs) of AD were calculated, along with prevalence on December 31, 2023. RESULTS: From 1980 to 2023, the mean age-standardized IR of AD was 318 cases per 100,000 person-years (95% CI: 294–342). The IR decreased with the introduction of ICD-10 (1997), but then sharply increased in 2001 following the addition of specialized outpatient data to the NPR that year, likely reflecting improved case ascertainment rather than a sudden true rise in incidence. As of December 31, 2023, the prevalence of AD in Sweden was 6.6% overall, 7.9% in adults, and 1.5% in children. CONCLUSIONS: In a nationwide study spanning more than 40 years, the IR of AD was 318 per 100,000 person-years but with substantial variation correlating to administrative changes in coding and content of the NPR. In 2023, the point prevalence of AD in Sweden was 1 in 15 individuals across all ages, 1 in 13 adults, and 1 in 67 children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177, Stockholm, Sweden. david.bergman.1@ki.se.
- Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Malmö, Sweden.
- Department of Clinical Sciences, Lund University and Department of Endocrinology, Nephrology and Rheumatology, Skane University Hospital, Lund, Sweden.
- Division of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177, Stockholm, Sweden.
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Bergman, D., Sundquist, K., Segelmark, M., Svedbom, A., Sun, J., Piehl, F., Yuan, S., Kämpe, O., Brodin, P., Ebrahimi, F., Askling, J., & Ludvigsson, J. F. (2026). Incidence and prevalence of autoimmune disease in the Swedish National Patient Register. European Journal of Epidemiology. https://doi.org/10.1007/s10654-026-01369-3
Vancouver
Bergman D, Sundquist K, Segelmark M, Svedbom A, Sun J, Piehl F, et al. Incidence and prevalence of autoimmune disease in the Swedish National Patient Register. European Journal of Epidemiology. 2026. doi:10.1007/s10654-026-01369-3
BibTeX
@article{Bergman2026,
author = {Bergman, David and Sundquist, Kristina and Segelmark, Mårten and Svedbom, Axel and Sun, Jiangwei and Piehl, Fredrik and Yuan, Shuai and Kämpe, Olle and Brodin, Petter and Ebrahimi, Fahim and Askling, Johan and Ludvigsson, Jonas F},
title = {Incidence and prevalence of autoimmune disease in the Swedish National Patient Register},
journal = {European Journal of Epidemiology},
year = {2026},
doi = {10.1007/s10654-026-01369-3}
}
EUVIMED